Unraveling The Genetics of Shared Clinical and Serological Manifestations in Systemic Inflammatory Autoimmune Diseases.


Journal

Arthritis & rheumatology (Hoboken, N.J.)
ISSN: 2326-5205
Titre abrégé: Arthritis Rheumatol
Pays: United States
ID NLM: 101623795

Informations de publication

Date de publication:
16 Sep 2024
Historique:
revised: 26 08 2024
received: 13 01 2024
accepted: 11 09 2024
medline: 17 9 2024
pubmed: 17 9 2024
entrez: 16 9 2024
Statut: aheadofprint

Résumé

Systemic inflammatory autoimmune diseases (SIADs) such as systemic lupus erythematosus (SLE), primary Sjögren's syndrome (pSS) and idiopathic inflammatory myopathies (myositis) are complex conditions characterized by shared circulating autoantibodies and clinical manifestations, including skin rashes, among others. This study aimed at elucidating the genetics underlying these common features. We performed targeted DNA sequencing of coding and regulatory regions from ~1,900 immune-related genes in a large SIAD cohort of 2,292 well-characterized Scandinavian patients with SLE, pSS and myositis, as well as 1,252 controls. A gene-based functionally-weighted genetic score for aggregate testing of all genetic variants, including rare variants, was complemented by in-silico functional analyses and in-vitro reporter experiments. Case-control association analysis detected known and potentially novel genetic loci in agreement with previous genetic and transcriptomics findings linked to the SIAD autoimmune background. Intriguingly, case-case comparisons between patient subgroups with and without specific autoantibodies revealed that the subgroups defined by ANA and anti-dsDNA antibodies have unique genetic profiles reflecting their heterogeneity. When focusing on clinical features, we overall showed that DUSP1 protective genetic variants lead to increased gene expression and potentially to anti-inflammatory effects on the SIAD-associated skin phenotype. This is consistent with recent genetic findings on eczema and with the previously reported downregulation of the MAPK signaling-related gene DUSP1 in other skin disorders. Together, this suggests common molecular mechanisms potentially underlying overlapping clinical manifestations shared among different disorders and informs clinical heterogeneity, which could be translated to improve disease diagnostic and treatment, also in more generalized disease frameworks.

Identifiants

pubmed: 39284741
doi: 10.1002/art.42988
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

This article is protected by copyright. All rights reserved.

Auteurs

Matteo Bianchi (M)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Sergey V Kozyrev (SV)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Antonella Notarnicola (A)

Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

Johanna K Sandling (JK)

Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden.

Mats Pettersson (M)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, Uppsala University, Uppsala, Sweden.

Dag Leonard (D)

Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden.

Christopher Sjöwall (C)

Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.

Iva Gunnarsson (I)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.

Solbritt Rantapää-Dahlqvist (S)

Department of Public Health and Clinical Medicine/Rheumatology, Umeå University, Umeå, Sweden.

Anders A Bengtsson (AA)

Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden.

Andreas Jönsen (A)

Department of Clinical Sciences Lund, Rheumatology, Lund University, Skåne University Hospital, Lund, Sweden.

Elisabet Svenungsson (E)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.

Helena Enocsson (H)

Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.

Marika Kvarnström (M)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.

Helena Forsblad-d'Elia (H)

Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.

Sara Magnusson Bucher (S)

Department of Rheumatology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Katrine B Norheim (KB)

Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway.

Eva Baecklund (E)

Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden.

Roland Jonsson (R)

Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.

Daniel Hammenfors (D)

Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.

Per Eriksson (P)

Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection, Linköping University, Linköping, Sweden.

Thomas Mandl (T)

Department of Clinical Sciences, Malmö, Division of Rheumatology, Lund University, Sweden.

Roald Omdal (R)

Research Department, Stavanger University Hospital, Stavanger, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway.

Leonid Padyukov (L)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden.

Helena Andersson (H)

Department of Rheumatology, Oslo University Hospital, 0372, Oslo, Norway.

Øyvind Molberg (Ø)

Department of Rheumatology, Oslo University Hospital, 0372 Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Louise Pyndt Diederichsen (L)

Department of Rheumatology, Odense University Hospital, Odense, Denmark; Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Ann-Christine Syvänen (AC)

Science for Life Laboratory, Uppsala University, Department of Medical Sciences, Molecular Precision Medicine, Uppsala, Sweden.

Marie Wahren-Herlenius (M)

Division of Rheumatology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden; Karolinska University Hospital, Stockholm, Sweden; Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.

Gunnel Nordmark (G)

Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden.

Ingrid E Lundberg (IE)

Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastro, Dermatology and Rheumatology, Karolinska University Hospital, Stockholm, Sweden.

Lars Rönnblom (L)

Department of Medical Sciences, Rheumatology, Uppsala University, Uppsala, Sweden.

Kerstin Lindblad-Toh (K)

Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden; Science for Life Laboratory, Uppsala University, Uppsala, Sweden; Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.

Classifications MeSH